Expertly Crafted Pe Anti-human Cd133 Your 95% Coupon Inside [Cs5HrbSN]

PE Anti-Human CD133 Antibody

The PE Anti-Human CD133 Antibody is a high-quality monoclonal antibody designed to specifically target the CD133 antigen. This antigen, also known as Prominin-1 and AC133, is a critical marker for various stem cells and cancer cells. The antibody is engineered to recognize human CD133, making it an invaluable tool for researchers studying hematopoietic stem cells, neuroepithelial cells, and cancer cells such as glioblastomas and leukemia cells. This antibody is a key component in the study of normal and cancerous tissues, offering researchers a powerful tool for exploring the complexities of stem cell biology and oncology.

Product Details

The PE Anti-Human CD133 Antibody, clone S16016E, is a monoclonal antibody of the IgG2a isotype. It is conjugated with PE (Phycoerythrin), a highly sensitive fluorochrome that allows for detection in flow cytometry applications. This antibody has been extensively tested for its fluorescent properties and is suitable for use in fluorescence-activated cell sorting (FACS). Key features of this product include its human specificity, high affinity to CD133, and compatibility with various detection systems. The product is supplied in a lyophilized form, ensuring stability and ease of use.

Applications and Benefits

The PE Anti-Human CD133 Antibody is ideal for a wide range of applications in cellular and molecular biology research. It is particularly useful for identifying and characterizing stem cells in normal and pathological conditions, as well as for monitoring the progression and response to cancer treatments. This antibody can be used in flow cytometry, immunohistochemistry, and other techniques that require specific staining and detection of CD133-positive cells. The product's high sensitivity and specificity make it a reliable choice for researchers in hematology, neurobiology, oncology, and stem cell research. By using this antibody, scientists can gain deeper insights into the biology of stem cells and cancer, leading to advancements in diagnosis, treatment, and prevention of these diseases.